본문으로 건너뛰기
← 뒤로

Migraine management: an update for the 2020s.

Internal medicine journal 2022 Vol.52(7) p. 1123-1128

Eller M, Cheng S

📝 환자 설명용 한 줄

Migraine is a common malady cutting across socioeconomic and ethnic divides in Australia.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Eller M, Cheng S (2022). Migraine management: an update for the 2020s.. Internal medicine journal, 52(7), 1123-1128. https://doi.org/10.1111/imj.15843
MLA Eller M, et al.. "Migraine management: an update for the 2020s.." Internal medicine journal, vol. 52, no. 7, 2022, pp. 1123-1128.
PMID 35879242
DOI 10.1111/imj.15843

Abstract

Migraine is a common malady cutting across socioeconomic and ethnic divides in Australia. It is typically diagnosed late with significant impact on quality of life. Management options have emerged over the past several years that promise simpler treatment regimens with less potential for side-effects. The development of rationally designed migraine preventives is the most significant advance in treatment since the development of the triptans and delivers significant hope to many headache sufferers.

MeSH Terms

Australia; Headache; Humans; Migraine Disorders; Quality of Life; Tryptamines